This website is intended for healthcare professionals only
Share this article
In a collaborative effort, Macquarie University, incorporating The Australian School of Advanced Medicine, together with Dalcross Private Hospital has launched an ambitious project to improve access to advanced radiosurgery and radiation therapy for patients in Sydney and across Australia’s New South Wales region.
The Stockholm-based medical technology group Elekta has been selected as the main provider of a comprehensive suit of cancer and neurosurgical treatment solutions and supporting IT systems to the new Macquarie University Private Hospital, currently under construction.
The Dalcross Private Hospital currently operates a facility that specialises in ophthalmology, neurosurgery, vascular surgery and ear nose and throat surgery. From mid 2009, Dalcross Hospital will also operate The Macquarie University Private Hospital – a joint venture with Macquarie University and its Australian School of Advanced Medicine, and which is currently being built on the university grounds.
“Technology for treating tumours and other disorders both in the brain and the body has advanced tremendously in recent years and there are many different systems on the market,” Carl Adams, CEO of Dalcross Private Hospital.
“After a thorough evaluation of several options, we chose dedicated radiosurgery and radiation therapy systems from Elekta, which will allow us to offer the most advanced treatments available to patients from Sydney and indeed all across Australia.”
“With both leading edge technology and workflow-supporting information management software, we will be able to create a department with seamless integration of the different treatment solutions provided by Elekta.”
Included in the project, Elekta will deliver the Leksell Gamma Knife Perfexion for non-invasive radiosurgery, Elekta Synergy digital linear accelerator systems for intensity modulated and image guided radiation therapy, the MOSAIQ information management system, MOSAIQ RTP and ERGO++ for radiation treatment planning, as well as Elekta’s 3mm micro-MLC for ultra precise radiation therapy.